statistiche ricercatore

Continente	#
NA - Nord America	967
AS - Asia	719
EU - Europa	541
SA - Sud America	85
AF - Africa	33
Continente sconosciuto - Info sul continente non disponibili	28
OC - Oceania	1
Totale	2.374

Nazione	#
US - Stati Uniti d'America	926
IT - Italia	259
SG - Singapore	231
VN - Vietnam	137
CN - Cina	117
BD - Bangladesh	67
HK - Hong Kong	64
BR - Brasile	61
IE - Irlanda	45
DE - Germania	42
FR - Francia	31
IN - India	29
FI - Finlandia	24
NL - Olanda	24
CA - Canada	23
GB - Regno Unito	20
ZA - Sudafrica	18
KR - Corea	17
RU - Federazione Russa	17
SE - Svezia	17
AT - Austria	16
TW - Taiwan	13
PL - Polonia	12
MX - Messico	9
ES - Italia	8
TR - Turchia	8
ID - Indonesia	6
AR - Argentina	5
CR - Costa Rica	5
UA - Ucraina	5
BE - Belgio	4
EC - Ecuador	4
IQ - Iraq	4
TH - Thailandia	4
VE - Venezuela	4
CI - Costa d'Avorio	3
CO - Colombia	3
EE - Estonia	3
SC - Seychelles	3
UZ - Uzbekistan	3
AE - Emirati Arabi Uniti	2
BO - Bolivia	2
CL - Cile	2
CW - ???statistics.table.value.countryCode.CW???	2
CZ - Repubblica Ceca	2
DZ - Algeria	2
IL - Israele	2
JP - Giappone	2
KZ - Kazakistan	2
MA - Marocco	2
MD - Moldavia	2
PH - Filippine	2
PY - Paraguay	2
RO - Romania	2
SA - Arabia Saudita	2
SK - Slovacchia (Repubblica Slovacca)	2
SY - Repubblica araba siriana	2
TN - Tunisia	2
AL - Albania	1
AU - Australia	1
BH - Bahrain	1
DO - Repubblica Dominicana	1
ET - Etiopia	1
HN - Honduras	1
HR - Croazia	1
HU - Ungheria	1
IR - Iran	1
JM - Giamaica	1
JO - Giordania	1
LB - Libano	1
LT - Lituania	1
MR - Mauritania	1
NO - Norvegia	1
PA - Panama	1
PE - Perù	1
PK - Pakistan	1
PT - Portogallo	1
SN - Senegal	1
UY - Uruguay	1
Totale	2.348

Nome	#
Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays	380
Development of a nasal spray based on cyclodextrin/hydrophobically-modified hydroxypropyl-methyl cellulose for the prevention of viral respiratory infections	362
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro	245
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler	218
Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects	179
Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2	172
Respicell(TM): An innovative dissolution apparatus for inhaled products	164
Fluorescence-enabled evaluation of nasal tract deposition and coverage of pharmaceutical formulations in a silicone nasal cast using an innovative spray device	137
Heparin-azithromycin microparticles show anti-inflammatory effects and inhibit SARS-CoV-2 and bacterial pathogens associated to lung infections	133
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023)	131
Drugs as contaminants of emerging concern: preventive approaches beyond detection, regulatory aspects and remediation	117
Long-acting inhaled medicines: Present and future	89
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases	47
Totale	2.374

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	11	0	0	0	0	6	0	0	0	0	0	1	4
2022/2023	68	2	3	1	4	1	2	11	9	20	8	4	3
2023/2024	109	6	2	2	6	9	9	30	6	3	3	14	19
2024/2025	436	9	11	9	49	35	36	42	32	45	37	46	85
2025/2026	1.294	75	80	130	109	140	61	136	69	162	122	153	57
2026/2027	456	239	66	70	81	0	0	0	0	0	0	0	0
Totale													2.374